Prokarium is a London-based biotech company focused on developing vaccines and immunotherapies based on engineering biology.
Prokarium has raised €33M across 2 funding rounds from 1 investor, most recently a round in Feb 2023. Based in London, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-02-09 | Other | €28M | — | View deal → |
| 2019-10-01 | Other | €5.2M | Wellcome Trust | View deal → |
